Boxer Capital, LLC Gossamer Bio, Inc. Transaction History

Boxer Capital, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$1.74 - $12.87 $408,900 - $3.02 Million	-235,000 Reduced 6.58%	3,336,928 $7.24 Million
Q3 2022 Nov 14, 2022	BUY	$7.21 - $14.88 $8 Million - $16.5 Million	1,109,570 Added 45.06%	3,571,928 $42.8 Million
Q3 2021 Nov 15, 2021	SELL	$7.25 - $13.23 $725,000 - $1.32 Million	-100,000 Reduced 3.9%	2,462,358 $31 Million
Q2 2020 Aug 14, 2020	BUY	$9.52 - $15.98 $3.59 Million - $6.03 Million	377,358 Added 17.27%	2,562,358 $33.3 Million
Q4 2019 Feb 14, 2020	BUY	$14.82 - $26.79 $1.63 Million - $2.95 Million	110,000 Added 5.3%	2,185,000 $34.2 Million
Q3 2019 Nov 14, 2019	BUY	$16.02 - $22.47 $3.2 Million - $4.49 Million	200,000 Added 10.67%	2,075,000 $34.8 Million
Q1 2019 May 15, 2019	BUY	$17.58 - $23.97 $33 Million - $44.9 Million	1,875,000 New	1,875,000 $40.6 Million

108

167M

430K

519K

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $93M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

Get notified when there are updates to the investment portfolio of Boxer Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Boxer Capital, LLC with notifications on news.